Quantitative Structure-Activity Relationship of Various Endogenous Estrogen Metabolites for Human Estrogen Receptor α and β Subtypes: Insights into the Structural Determinants Favoring a Differential Subtype Binding
The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Abstract
To search for endogenous estrogens that may have preferential binding affinity for human estrogen receptor (ER) α or β subtype and also to gain insights into the structural determinants favoring differential subtype binding, we studied the binding affinities of 74 natural or synthetic estrogens, including more than 50 steroidal analogs of estradiol-17β (E2) and estrone (E1) for human ERα and ERβ. Many of the endogenous estrogen metabolites retained varying degrees of similar binding affinity for ERα and ERβ, but some of them retained differential binding affinity for the two subtypes. For instance, several of the D-ring metabolites, such as 16α-hydroxyestradiol (estriol), 16β-hydroxyestradiol-17α, and 16-ketoestrone, had distinct preferential binding affinity for human ERβ over ERα (difference up to 18-fold). Notably, although E2 has nearly the highest and equal binding affinity for ERα and ERβ, E1 and 2-hydroxyestrone (two quantitatively predominant endogenous estrogens in nonpregnant woman) have preferential binding affinity for ERα over ERβ, whereas 16α-hydroxyestradiol (estriol) and other D-ring metabolites (quantitatively predominant endogenous estrogens formed during pregnancy) have preferential binding affinity for ERβ over ERα. Hence, facile metabolic conversion of parent hormone E2 to various metabolites under different physiological conditions may serve unique functions by providing differential activation of the ERα or ERβ signaling system. Lastly, our computational three-dimensional quantitative structure-activity relationship/comparative molecular field analysis of 47 steroidal estrogen analogs for human ERα and ERβ yielded useful information on the structural features that determine the preferential activation of the ERα and ERβ subtypes, which may aid in the rational design of selective ligands for each human ER subtype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“E2 has the highest affinity for ERα and ERβ and is thus considered the strongest estrogen (121).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [121]
In the citing paper
“E1 and E3 are weaker estrogens, with higher affinity for ERα and ERβ, respectively (121).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [121]
In the citing paper
“E2, or 17β-estradiol, is the predominant estrogen in premenopausal women, and it is the more biologically active form as it has a higher affinity for estrogen receptors than other estrogen forms during reproductive years (121).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [121]
Citations
Cites
Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94
Halgren, T. A. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<490::aid-jcc1>3.0.co;2-p · Cited by 5,306
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous system
Shughrue, P. J., Lane, M. V., & Merchenthaler, I. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971201)388:4<507::aid-cne1>3.0.co;2-6 · Cited by 2,259
Nilsson, S., Mäkelä, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., & Gustafsson, J.-Å. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1535 · Cited by 1,996
Sequence and Expression of Human Estrogen Receptor Complementary DNA
Greene, G. L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., & Shine, J. (1986) · Science · doi:10.1126/science.3753802 · Cited by 1,311
Human Estrogen Receptor β-Gene Structure, Chromosomal Localization, and Expression Pattern1
Enmark, E., Pelto-Huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjöld, M., & Gustafsson, J.-A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4470 · Cited by 1,074
Research works printed but not linked: 4
- Katzenellenbogen, 1982, In vivo and in vitro steroid receptor assays in the design of estrogen pharmaceuticals, 93
- Fishman, 1981, Biological action of catecholestrogens, J Endocr, 85, 59P
- MacLusky, 1983, Catechol estrogens and estrogen receptors, 151
- Fanchenko, 1979, The specificity of human estrogen receptor, Acta Endocrinol, 7, 232
Cited by
Liu, Z.-H., Kanjo, Y., & Mizutani, S. (2009) · Science of The Total Environment · doi:10.1016/j.scitotenv.2008.08.039 · Cited by 729
The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer
(2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw029 · Cited by 523
Uterine Microbiota: Residents, Tourists, or Invaders?
Baker, J. M., Chase, D. M., & Herbst-Kralovetz, M. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00208 · Cited by 392
Fuhrman, B. J., Feigelson, H. S., Flores, R., Gail, M. H., Xu, X., Ravel, J., & Goedert, J. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2222 · Cited by 339
“The parent estrogens (estrone and estradiol) may be irreversibly hydroxylated at the C-2, C-4, or C-16 positions of the steroid ring, resulting in a wide array of estrogen metabolites that vary in bioavailability (3) and estrogenicity (4).”
BackgroundProssnitz, E. R., & Arterburn, J. B. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009712 · Cited by 258
“The E2 metabolite 2-hydroxyestradiol exhibits highaffinity binding for recombinant human ERa/b with relative binding affinities reduced fivefold and threefold relative to E2, respectively (Zhu et al., 2006a).”
BackgroundThe Effects of Soy Isoflavones on Obesity
Ørgaard, A., & Jensen, L. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-347 · Cited by 221
“E2 has equal binding affinities for ER a and ER b (18), whereas the isoflavones genistein and daidzein have greater binding affinity for ER b than for ER a (17, 18).”
BackgroundEstrogen Metabolism and Risk of Breast Cancer in Postmenopausal Women
Fuhrman, B. J., Schairer, C., Gail, M. H., Boyd-Morin, J., Xu, X., Sue, L. Y., Buys, S. S., Isaacs, C., Keefer, L. K., Veenstra, T. D., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr531 · Cited by 205
Liu, Z.-H., Kanjo, Y., & Mizutani, S. (2009) · Science of The Total Environment · doi:10.1016/j.scitotenv.2009.06.001 · Cited by 199
“For the same hERα-Binding assay, the RBA of some natural estrogens also differed and the RBA of 16keto-estradiol by NITE (2008) was about 31 times higher than that found by Zhu et al. (2006).”
ResultThe Role of the Estrogen Pathway in the Tumor Microenvironment
Rothenberger, N., Somasundaram, A., & Stabile, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020611 · Cited by 190
Progress in solving the sex hormone paradox in pulmonary hypertension
Lahm, T., Tuder, R. M., & Petrache, I. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00337.2013 · Cited by 167
Synthesis of an aromatic N-heterocycle derived from biomass and its use as a polymer feedstock
Yu, Q., Wang, J., Kou, Y., Pang, H., Zhang, S., Li, N., Liu, C., Weng, Z., & Jian, X. (2019) · Nature Communications · doi:10.1038/s41467-019-10178-0 · Cited by 159
Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease
Khalil, R. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.09.024 · Cited by 167
Saponins as modulators of nuclear receptors
Zhang, T., Zhong, S., Li, T., & Zhang, J. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1514580 · Cited by 152
“Quantitative structure-activity relationship (QSAR) studies show that endogenous estrogen metabolites retain differential binding affinity for the two ER subtypes (Zhu et al. 2006).”
BackgroundSmall Molecules for Active Targeting in Cancer
Kue, C. S., Kamkaew, A., Burgess, K., Kiew, L. V., Chung, L. Y., & Lee, H. B. (2016) · Medicinal Research Reviews · doi:10.1002/med.21387 · Cited by 141
Yang, J., Tan, Q., Fu, Q., Zhou, Y., Hu, Y., Tang, S., Zhou, Y., Zhang, J., Qiu, J., & Lv, Q. (2016) · Breast Cancer · doi:10.1007/s12282-016-0734-z · Cited by 149
“wide array of estrogen metabolites and gain estrogenicity accordingly through variable concentrations of microbial b-glucuronidase [47].”
BackgroundGencel, V. B., Benjamin, M. M., Bahou, S. N., & Khalil, R. A. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712798995020 · Cited by 149
Estrogens and the risk of breast cancer: A narrative review of literature
Al‐Shami, K., Awadi, S., Khamees, A., Alsheikh, A. M., Al-Sharif, S., Bereshy, R., Al-Eitan, S. F., Banikhaled, S. H., Al-Qudimat, A. R., Al‐Zoubi, R. M., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20224 · Cited by 180
“Both receptors interact in the same way with endogenous estrogens, mostly with 17 β -estradiol (E2) [44].”
Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response
Mair, K. M., Johansen, A. K. Z., Wright, A. F., Wallace, E., & MacLean, M. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12281 · Cited by 131
“Interestingly, 17β oestradiol, 4-hydroxyestradiol and 4- hydroxyestrone and 2-hydroxyestradiol have an equal binding affinity for both ERα and ERβ receptors, whereas oestrone and 2-hydroxyestrone preferentially bind at ERα (Zhu et al., 2006).”
BackgroundInfluentialEstrogenic Compounds, Estrogen Receptors and Vascular Cell Signaling in the Aging Blood Vessels
Smiley, D., & Khalil, R. A. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788186093 · Cited by 118
“Metabolites such as C-3 sulfated estrogens (E1-3-sulfate and E2-3-sulfate) have little affinity for ERα and ERβ, while 16α-OH-E1 has a higher affinity than E1 [15].”
BackgroundThe transition to motherhood: linking hormones, brain and behaviour
Servin-Barthet, C., Martínez‐Garcia, M., Pretus, C., Paternina-Die, M., Soler, A., Khymenets, O., Pozo, Ó. J., Leuner, B., Vilarroya, Ó., & Carmona, S. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00733-6 · Cited by 123
Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women
Moore, S. C., Matthews, C. E., Shu, X. O., Yu, K. F., Gail, M. H., Xu, X., Ji, B., Chow, W., Cai, Q., Li, H., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw103 · Cited by 107
Metabolic and Epigenetic Regulation by Estrogen in Adipocytes
Bjune, J.-I., Panahandeh, P., Jersin, R. Å., Mellgren, G., & Dankel, S. N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.828780 · Cited by 122
Crespillo, A., Alonso, M., Vida, M., Pavón, F. J., Serrano, A., Rivera, P., Romero‐Zerbo, S., Fernández‐Llebrez, P., Martínez, A., Perez‐Valero, V., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01477.x · Cited by 100
Gender and sex hormones in multiple sclerosis pathology and therapy
Nicot, A. B. (2009) · Frontiers in bioscience · doi:10.2741/3543 · Cited by 108
Eliassen, A. H., Spiegelman, D., Xu, X., Keefer, L. K., Veenstra, T. D., Barbieri, R. L., Willett, W. C., Hankinson, S. E., & Ziegler, R. G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2507 · Cited by 94
“Despite the estrogenic and genotoxic potential of many of the EM, we only observed a significantly increased breast cancer risk with one EM, 17-epiestriol, which has particularly strong estrogenic activity and binds to both ERα and ERβ with an affinity comparable to estradiol (51).”
BackgroundChow, H.-H. S., Garland, L. L., Heckman-Stoddard, B. M., Hsu, C.-H., Butler, V. D., Cordova, C. A., Chew, W. M., & Cornelison, T. L. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0223-0 · Cited by 92
Epidemiologic studies of estrogen metabolism and breast cancer
Ziegler, R. G., Fuhrman, B. J., Moore, S. C., & Matthews, C. E. (2015) · Steroids · doi:10.1016/j.steroids.2015.02.015 · Cited by 100
Mahmoud, A. M., Al‐Alem, U., Ali, M. M., & Bosland, M. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.04.018 · Cited by 84
Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice
Tiwari-Woodruff, S., & Voskuhl, R. R. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.04.023 · Cited by 81
“The very high levels of estriol present during pregnancy may produce a differential activation of the ERβ signaling system in the pregnant woman and fetus for fulfilling various unique physiological functions(45).”
BackgroundTang, Z., Liu, Z., Wang, H., Dang, Z., Yin, H., Zhou, Y., & Liu, Y. (2020) · Water Research · doi:10.1016/j.watres.2020.115976 · Cited by 83
Pillerová, M., Borbélyová, V., Hodosy, J., RILJAK, V., Renczés, E., Frick, K. M., & Tóthová, Ľ. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100926 · Cited by 83
“Various estrogens have different affinities to these ERs: 17β-estradiol (E2) has equal affinity to both, whereas estrone preferentially binds to ERα and estriol to ERβ (Zhu et al., 2006).”
Background17β‐estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain
Gerstner, B., Lee, J., DeSilva, T. M., Jensen, F. E., Volpe, J. J., & Rosenberg, P. A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22023 · Cited by 86
“The Kd values of E2 for recombinant human ER-a and ER-b are 0.7 and 0.75 nM, comparable to the EC50 value of 1.3 nM obtained in this study.”
BackgroundInfluentialXu, X., Keefer, L. K., Ziegler, R. G., & Veenstra, T. D. (2007) · Nature Protocols · doi:10.1038/nprot.2007.176 · Cited by 77
Androgens, oestrogens and endometrium: a fine balance between perfection and pathology
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0106 · Cited by 76
Hong, H., Harvey, B. G., Palmese, G. R., Stanzione, J. F., Ng, H. W., Sakkiah, S., Tong, W., & Sadler, J. M. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13070705 · Cited by 81
Dallal, C. M., Tice, J. A., Buist, D. S. M., Bauer, D. C., Lacey, J. V., Cauley, J. A., Hue, T. F., LaCroix, A., Falk, R. T., Pfeiffer, R. M., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt367 · Cited by 73
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Sun, J., Song, S., Liu, J., Chen, F., Li, X., & Wu, G. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00678-x · Cited by 89
Holtorf, K. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.01.1949 · Cited by 82
Hevir, N., Šinkovec, J., & Rižner, T. L. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.09.011 · Cited by 69
Falk, R. T., Xu, X., Keefer, L., Veenstra, T. D., & Ziegler, R. G. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0355 · Cited by 67
“Evidence is accumulating that substantial differences exist in the genotoxic, mutagenic, and proliferative activities of the individual estrogens and EM and that these differences may play a role in breast cancer etiology (5, 8-13).”
BackgroundMasood, D.-E.-N., Roach, E. C., Beauregard, K. G., & Khalil, R. A. (2010) · Current Drug Metabolism · doi:10.2174/138920010794233477 · Cited by 77
Flavonoids as dietary regulators of nuclear receptor activity
Avior, Y., Bomze, D., Ramon, O., & Nahmias, Y. (2013) · Food & Function · doi:10.1039/c3fo60063g · Cited by 77
Rivera, P., Pérez-Martín, M., Pavón, F. J., Serrano, A., Crespillo, A., Cifuentes, M., López-Ávalos, M.-D., Grondona, J. M., Vida, M., Fernández-Llebrez, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064750 · Cited by 65
Jayshree, R. S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.649815 · Cited by 73
“Estradiol and estrone are parent forms of estrogens—they initially get metabolized in the liver yielding metabolites having diverse potencies as hormones (Zhu et al., 2006).”
BackgroundEstrogen plays an important role by influencing the NLRP3 inflammasome
Dong, W., Peng, Q., Liu, Z., Xie, Z., Guo, X., Li, Y., & Chen, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115554 · Cited by 75
Machuki, J. O., Zhang, H., Harding, S. E., & Sun, H. (2017) · Acta Physiologica · doi:10.1111/apha.12978 · Cited by 73
“It has been postulated that the balance between oestrogen forms is responsible for activation of different signalling pathways under certain physiological conditions based on the premise that ERs possess different affinities for each oestrogen subtype.(78) Furthermore, 17b-oestradiol synthesis occurs through enzymatic…”
BackgroundFessel, J. P., Chen, X., Frump, A. L., Gladson, S., Blackwell, T., Kang, C., Johnson, J. A., Loyd, J. E., Hemnes, A. R., Austin, E. D., et al. (2013) · Pulmonary Circulation · doi:10.1086/674312 · Cited by 60
“By classical methods to assess estrogen receptor binding affinity, 16αOHE possesses only a fraction of the binding affinity of E2, with greater affinity for ERβ.(43) However, 16αOHE has been shown to bind covalently (i.”
BackgroundSchwartz, E., & Holtorf, K. (2008) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2008.07.015 · Cited by 60
Placental contribution to the endocrinology of gestation and parturition
Schuler, G. C., Fürbaß, R., & Klisch, K. (2018) · Animal Reproduction · doi:10.21451/1984-3143-ar2018-0015 · Cited by 71
“Eventually functions mediated by membrane bound receptors and other non-classical signaling pathways also must be taken into account (Zhu et al., 2006; Cheskis et al., 2007).”
BackgroundSaggar, J. K., Chen, J., Corey, P., & Thompson, L. U. (2010) · Nutrition and Cancer · doi:10.1080/01635580903532440 · Cited by 58
Comparison of estrogenic components used for hormonal contraception
Stanczyk, F. Z., Winer, S. A., Foidart, J., & Archer, D. F. (2023) · Contraception · doi:10.1016/j.contraception.2023.110310 · Cited by 67
Bartkowiak-Wieczorek, J., Jaros, A., Gajdzińska, A., Wojtyła-Buciora, P., Szymański, I., Szymaniak, J., Janusz, W., Walczak, I., Jonaszka, G., & Bienert, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158167 · Cited by 70
“Unlike E2, most compounds in the phytoestrogen group exhibit greater affinity for the ER-β than for the ER-α [176–178].”
BackgroundRaveendran, R., Chen, F., Kent, B., & Stenzel, M. H. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.9b01681 · Cited by 54
Marchais‐Oberwinkler, S., Wetzel, M., Ziegler, E., Kruchten, P., Werth, R., Henn, C., Hartmann, R. W., & Frotscher, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1009082 · Cited by 55
Komorowski, A. S., & Pezo, R. C. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05472-w · Cited by 57
Bernstein, S. R., Kelleher, C., & Khalil, R. A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115737 · Cited by 57
Trullemans, L., Koelewijn, S.-F., Scodeller, I., Hendrickx, T., Puyvelde, P. V., & Sels, B. F. (2021) · Polymer Chemistry · doi:10.1039/d1py00909e · Cited by 60
Bhallamudi, S., Connell, J. M., Pabelick, C. M., Prakash, Y. S., & Sathish, V. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00206.2019 · Cited by 55
Handelsman, D. J., Gibson, E., Davis, S. R., Golebiowski, B., Walters, K. A., & Desai, R. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa086 · Cited by 53
Hormonal Regulation of BCRP Expression in Human Placental BeWo Cells
Wang, H., Unadkat, J. D., & Mao, Q. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9432-z · Cited by 51
Wober, J., Möller, F. J., Richter, T., Unger, C., Weigt, C., Jandausch, A., Zierau, O., Rettenberger, R., Kaszkin-Bettag, M., & Vollmer, G. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.04.002 · Cited by 47
Circulating Estrogen Metabolites and Risk of Breast Cancer in Postmenopausal Women
Arslan, A. A., Koenig, K. L., Lenner, P., Afanasyeva, Y., Shore, R. E., Chen, Y., Lundin, E., Toniolo, P., Hallmans, G., & Zeleniuch-Jacquotte, A. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0009 · Cited by 45
17β-HSD2 inhibitors for the treatment of osteoporosis: Identification of a promising scaffold
Wetzel, M., Marchais‐Oberwinkler, S., & Hartmann, R. W. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.013 · Cited by 46
Probing the origin of estrogen receptor alpha inhibition via large-scale QSAR study
Suvannang, N., Preeyanon, L., Malik, A. A., Schaduangrat, N., Shoombuatong, W., Worachartcheewan, A., Tantimongcolwat, T., & Nantasenamat, C. (2018) · RSC Advances · doi:10.1039/c7ra10979b · Cited by 49
Adrenoceptors: Non Conventional Target for Breast Cancer?
Lüthy, I. A., Bruzzone, A., Piñero, C. P., Castillo, L., Chiesa, I. J., Vazquez, S., & Sarappa, M. G. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788186048 · Cited by 43
“Curiously, this 17-keto function reduces the binding to the ER [60].”
BackgroundRobb, E. L., & Stuart, J. A. (2013) · Phytochemistry · doi:10.1016/j.phytochem.2013.11.019 · Cited by 42
“, 2011), which has been demonstrated in vitro (Bowers et al., 2000; Zhu et al., 2006).”
Dual roles of estrogen metabolism in mammary carcinogenesis
Chang, M. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.7.423 · Cited by 53
“The catechol estrogen metabolites have high binding affinities to the ER at a comparable level to E2 itself and induce estrogen-responsive gene expression via classical ER-mediated pathways (23, 77).”
BackgroundStrande, L., Strand, S. E., Kalhorn, T. F., & Stensel, H. D. (2009) · Environmental Science & Technology · doi:10.1021/es901194c · Cited by 40
Measuring Estrogens and Progestagens in Humans: An Overview of Methods
Bellem, A., Meiyappan, S., Romans, S. E., & Einstein, G. (2011) · Gender Medicine · doi:10.1016/j.genm.2011.07.001 · Cited by 47
Johansen, A. K. Z., Dean, A., Morecroft, I., Hood, K. Y., Nilsen, M., Loughlin, L., Anagnostopoulou, A., Touyz, R. M., White, K., & MacLean, M. R. (2016) · Pulmonary Circulation · doi:10.1086/685023 · Cited by 40
Sun, Y., Sangam, S., Guo, Q., Wang, J., Tang, H., Black, S. M., & Desai, A. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.719058 · Cited by 45
“Hydroxylation of E1 at this C2 position generates 2hydroxyestrone (2-OHE1), which has a higher ability to bind ERα than ERβ (50).”
BackgroundEnteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 37
“The types of estrogen and their modifications influence their preference for and capacity to activate different types of estrogen receptors (ERs) [526].”
BackgroundFuhrman, B. J., Xu, X., Falk, R. T., Dallal, C. M., Veenstra, T. D., Keefer, L. K., Graubard, B. I., Brinton, L. A., Ziegler, R. G., & Gierach, G. L. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0438 · Cited by 36
“Because EMs vary with respect to bioavailability (6), affinities for the estrogen receptors (7), and mutagenic potential (8, 9), many investigators have hypothesized that differences in estrogen metabolism profiles may”
BackgroundSpadaro, A., Negri, M., Marchais‐Oberwinkler, S., Bey, E., & Frotscher, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029252 · Cited by 39
Fernández-Murga, M. L., Gil-Ortiz, F., Serrano-García, L., & Llombart‐Cussac, A. (2023) · Pathogens · doi:10.3390/pathogens12091086 · Cited by 37
The Impact of Estrogen in the Tumor Microenvironment
Somasundaram, A., Rothenberger, N. J., & Stabile, L. P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-50224-9_2 · Cited by 40
Yearley, E. J., Zhurova, E. A., Zhurov, V. V., & Pinkerton, A. A. (2008) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2008.03.053 · Cited by 38
Ku, L. T., Gerçel-Taylor, Ç., Nakajima, S. T., & Taylor, D. D. (2009) · Immunity & Ageing · doi:10.1186/1742-4933-6-1 · Cited by 35
Development of estrogen receptor beta binding prediction model using large sets of chemicals
Sakkiah, S., Selvaraj, C., Gong, P., Zhang, C., Tong, W., & Hong, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21723 · Cited by 39
Bacsa, I., Herman, B. E., Jójárt, R., Herman, K. S., Woelfling, J., Schneider, G., Varga, M., Tömböly, C., Rižner, T. L., Szécsi, M., et al. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1490731 · Cited by 36
Unraveling FATP1, regulated by ER-β, as a targeted breast cancer innovative therapy
Mendes, C., Lopes‐Coelho, F., Ramos, C., Martins, F., Santos, I. P., Rodrigues, A., SILVA, F. A. B. N. D., André, S., & Serpa, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-50531-3 · Cited by 41
Quantification of Estradiol Uptake in Zebrafish Embryos and Larvae
Souder, J. P., & Gorelick, D. A. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx107 · Cited by 36
“E2 and its metabolites may have different affinities for estrogen receptors (Zhu et al., 2006), therefore distinguishing between E2 metabolites is important for understanding how E2 exerts a particular effect.”
BackgroundCirculating Estrogen Metabolites and Risk for Breast Cancer in Premenopausal Women
Arslan, A. A., Shore, R. E., Afanasyeva, Y., Koenig, K. L., Toniolo, P. G., & Zeleniuch‐Jacquotte, A. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0312 · Cited by 33
“The 2-hydroxyestrogens bind to the estrogen receptor with affinity comparable with that of estradiol (20, 21) but have limited mitogenic effect (22, 23) and possibly even antiestrogenic effects (18, 24).”
BackgroundThe Progress of Research on Genetic Factors of Recurrent Pregnancy Loss
Li, Q., Chen, S., Dong, X., Fu, S., Zhang, T., Zheng, W., Tian, Y., & Huang, D. (2023) · Genetics Research · doi:10.1155/2023/9164374 · Cited by 42
Characterization of the Estradiol-Binding Site Structure of Human Protein Disulfide Isomerase (PDI)
Fu, X., Wang, P., & Zhu, B. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027185 · Cited by 31
Self-citationChoi, H. J., Lee, A. J., Kang, K. S., Song, J. H., & Zhu, B. T. (2020) · Scientific Reports · doi:10.1038/s41598-020-62984-y · Cited by 30
Self-citationIde, H., & Miyamoto, H. (2021) · Cells · doi:10.3390/cells10051169 · Cited by 42
Understanding nuclear receptors using computational methods
Ai, N., Krasowski, M. D., Welsh, W. J., & Ekins, S. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.03.003 · Cited by 33
“A recent analysis of 74 natural or synthetic estrogens by a QSAR model yielded useful information on structural features for preferential activation of the ERα and ERβ subtypes[48].”
BackgroundHormone Replacement Therapy and Cardiovascular Health in Postmenopausal Women
Xia, W., & Khalil, R. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115078 · Cited by 41
Beekmann, K., de Haan, L. H. J., Actis‐Goretta, L., Houtman, R., van BLADEREN, P. J., & Rietjens, I. M. C. M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.09.002 · Cited by 37
Simon, C., Onghena, M., Covaci, A., Hoeck, E. V., Loco, J. V., Vandermarken, T., Langenhove, K. V., Demaegdt, H., Mertens, B., Vandermeiren, K., et al. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.09.008 · Cited by 35
“…endogenous oestrogen, 17β-oestradiol (E2) shows similar affinity for both ER subtypes, with a Kd for ERα and ERβ of 0.70 nM and 0.75 nM respectively (Zhu et al, 2006), some ligands show a higher affinity for hERα, i.e. genistein or display an agonistic activity on hERα and an antagonistic…”
BackgroundInfluentialEstrogen Metabolites Are Not Associated with Colorectal Cancer Risk in Postmenopausal Women
Falk, R. T., Dallal, C. M., Lacey, J. V., Bauer, D. C., Buist, D. S. M., Cauley, J. A., Hue, T. F., LaCroix, A. Z., Tice, J. A., Pfeiffer, R. M., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0541 · Cited by 29
“Estradiol binds to both receptors with comparably high affinity, but at least one estrogen metabolite (EM), 17-epiestriol, shows a binding preference for ERβ (7).”
The oxysterome and its receptors as pharmacological targets in inflammatory diseases
Guillemot‐Legris, O., & Muccioli, G. G. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15479 · Cited by 32
Impact of Estrogens on the Regulation of White, Beige, and Brown Adipose Tissue Depots
Bernasochi, G. B., Bell, J. R., Simpson, E. R., Delbridge, L. M. D., & Boon, W. C. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180009 · Cited by 37
The Role of Estrone in Feminizing Hormone Treatment
Tebbens, M., Heijboer, A. C., T'Sjoen, G. G., Bisschop, P. H. L. T., & den Heijer, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab741 · Cited by 27
Tang, Z., Wan, Y., Liu, Z., Wang, H., Dang, Z., & Liu, Y. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.150042 · Cited by 26
Ding, J. P., & Zhu, B. T. (2007) · Steroids · doi:10.1016/j.steroids.2007.10.012 · Cited by 26
Self-citationLee, A. A., & Den Hartigh, L. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682231 · Cited by 32
Khalil, R. A. (2010) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152510790796156 · Cited by 24
Mallia, V., Ivanova, L., Eriksen, G. S., Harper, E., Connolly, L., & Uhlig, S. (2020) · Toxins · doi:10.3390/toxins12040228 · Cited by 25
“A large number of estradiol-metabolites have been shown, and they have different estrogenic potency [52,53].”
Background
Metadata
- Authors
- Zhu, B. T., Han, G.-Z., Shim, J.-Y., Wen, Y., & Jiang, X.-R.
- Affiliations
- University of South Carolina (US)
- North Carolina Central University (US)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-09-01
- Volume
- 147
- Issue
- 9
- Pages
- 4132-4150
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2147478280
- Cited by
- 271
- References
- 62
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 17 · 2023: 13 · 2022: 12 · 2021: 15 · 2020: 10 · 2019: 12 · 2018: 12 · 2017: 8 · 2016: 12 · 2015: 15 · 2014: 14 · 2013: 15 · 2012: 18
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of South Carolina
- North Carolina Central University
- National Cancer Institute (R01CA092391, R01CA097109, R01-CA97109, R01 CA 92391)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Health Sciences › Nursing › Nutrition and Dietetics › Phytoestrogen effects and research
- Keywords
- estrogen receptor alpha, estrogen receptor beta, estradiol, estrone, 2-hydroxyestrone, steroid analogues, CoMFA, 3D-QSAR, estrogen metabolism, pregnancy
- MeSH terms
- Diethylstilbestrol, Estradiol, Estriol, Estrogen Antagonists, Estrogens, Estrone, Humans, Hydroxyestrones, Models, Molecular, Molecular Structure, Signal Transduction, Quantitative Structure-Activity Relationship, Estrogen Receptor alpha, Estrogen Receptor beta, Phytoestrogens, Static Electricity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.